Health Care • Biotechnology: Biological Products (No Diagnostic Substances)
$3.06 ▼ -0.07
(-2.24%)
MKT CAP: $251.1M • VOL: 1.05M
52W L $3 52W H $11
ROARABLE / RQD
D- • 36/100
PIOTROSKI
2 / 9
LXEO CHAT <GO> // SEC 10-K & XBRL FORENSIC RAGLexeo Therapeutics Inc. • CIK 0001907108
EDGAR XBRL + ITEM 1A/7FREE QUERIES: 2/2
INSTITUTIONAL AUDIT PROMPTS [CLICK TO EXECUTE]STRUCTURED CITATION ENGINE
[READY // SEC EDGAR & XBRL VECTOR WORKSTATION]
Select an audit prompt above or enter any fundamental, 10-K Risk Factor (Item 1A), MD&A (Item 7), free cash flow conversion, or FRED macro-correlation query on LXEO. Every response cites verified XBRL line items and SEC filing sections.